Fosun Pharmaceutical Group
Tracked across 6 events · 40 articles · First seen Apr 01, 2026 · Last active Sep 07, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Announced H-share repurchase and partial disposal of Gland Pharma stake, signaling confidence and improving shareholder returns.
Jul 20, 2026 · 6 articles
Business
Impact: Fosun Pharmaceutical Group's subsidiary, Fosun International — Fosun Wanbang Pharma Group, entered into a strategic partnership with Shanghai Junshi Biosciences Co., Ltd, which is a vital step in continuously enriching its portfolio of high-value pipelines in the immunology and inflammation fields.
Jul 01, 2026 · 8 articles
Business
Impact: Fosun Pharmaceutical Group is a core revenue contributor and a key beneficiary of Fosun's innovation investments. Its strong performance and R&D pipeline are central to the group's growth story.
Jul 20, 2026 · 6 articles
Business
Impact: Advanced drug pipeline and supplied artesunate for malaria, saving millions of patients.
Aug 06, 2026 · 6 articles
Business
Impact: Parent of Fosun International — Fosun Wanbang Pharma Group; licensing agreement for roconkibart provides Junshi with upfront and milestone payments.
Aug 26, 2026 · 8 articles
Business
Impact: Fosun Pharmaceutical Group has an approved New Drug Application for tenapanor for hyperphosphatemia in China, a product related to Ardelyx's pipeline.
Apr 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Fosun Pharmaceutical Group live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard